TY - JOUR AU - Lange, C. AU - Chesov, D. AU - Heyckendorf, J. AU - Leung, C. C. AU - Udwadia, Z. AU - Dheda, K. PY - 2018 DA - 2018// TI - Drug-resistant tuberculosis: an update on disease burden, diagnosis and treatment JO - Respirology. VL - 23 UR - https://doi.org/10.1111/resp.13304 DO - 10.1111/resp.13304 ID - Lange2018 ER - TY - STD TI - WHO. Global Tuberculosis Report 2019 Geneva: world health organization; 2019 [updated 17 October 2019. Available from: https://www.who.int/tb/publications/global_report/en/. UR - https://www.who.int/tb/publications/global_report/en/ ID - ref2 ER - TY - STD TI - WHO. MDR-TB factsheet 2018 Geneva 2018 [updated 2018. Available from: https://www.who.int/tb/areas-of-work/drug-resistant-tb/MDR-RR_TB_factsheet_2018_Apr2019.pdf?ua=1. UR - https://www.who.int/tb/areas-of-work/drug-resistant-tb/MDR-RR_TB_factsheet_2018_Apr2019.pdf?ua=1 ID - ref3 ER - TY - JOUR AU - Murray, C. J. AU - Ortblad, K. F. AU - Guinovart, C. AU - Lim, S. S. AU - Wolock, T. M. AU - Roberts, D. A. PY - 2014 DA - 2014// TI - Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the global burden of disease study 2013 JO - Lancet. VL - 384 UR - https://doi.org/10.1016/S0140-6736(14)60844-8 DO - 10.1016/S0140-6736(14)60844-8 ID - Murray2014 ER - TY - JOUR AU - Long, Q. AU - Qu, Y. AU - Lucas, H. PY - 2016 DA - 2016// TI - Drug-resistant tuberculosis control in China: progress and challenges JO - Infect Dis Poverty. VL - 5 UR - https://doi.org/10.1186/s40249-016-0103-3 DO - 10.1186/s40249-016-0103-3 ID - Long2016 ER - TY - JOUR AU - Wang, L. AU - Liu, J. AU - Chin, D. P. PY - 2007 DA - 2007// TI - Progress in tuberculosis control and the evolving public-health system in China JO - Lancet. VL - 369 UR - https://doi.org/10.1016/S0140-6736(07)60316-X DO - 10.1016/S0140-6736(07)60316-X ID - Wang2007 ER - TY - JOUR AU - Zhou, C. AU - Jiang, W. AU - Yuan, L. AU - Lu, W. AU - He, J. AU - Zhao, Q. PY - 2016 DA - 2016// TI - Access to bacteriologic-based diagnosis in smear positive retreatment tuberculosis patients in rural China: a cross-sectional study in three geographic varied provinces JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0146340 DO - 10.1371/journal.pone.0146340 ID - Zhou2016 ER - TY - JOUR AU - Zhang, X. L. AU - Yin, J. AU - Li, H. T. AU - Li, S. G. AU - Walley, J. AU - Zou, G. Y. PY - 2015 DA - 2015// TI - Diagnostic and treatment delays of multidrug-resistant tuberculosis before initiating treatment: a cross-sectional study JO - Tropical Med Int Health VL - 20 UR - https://doi.org/10.1111/tmi.12566 DO - 10.1111/tmi.12566 ID - Zhang2015 ER - TY - JOUR AU - Yang, Z. AU - Zhou, C. AU - Ning, Z. AU - Lu, W. AU - Zhao, Q. AU - Hu, Y. PY - 2018 DA - 2018// TI - High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis JO - Glob Health Action VL - 11 UR - https://doi.org/10.1080/16549716.2018.1500763 DO - 10.1080/16549716.2018.1500763 ID - Yang2018 ER - TY - STD TI - Chen Y, Zhao Y. Multidrug-resistant tuberculosis in rural China: lack of public awareness, unaffordable costs and poor clinical management. Case Reports. 2018;2018:bcr-2018-225794. ID - ref10 ER - TY - JOUR AU - Zhang, Y. AU - Wu, S. AU - Xia, Y. AU - Wang, N. AU - Zhou, L. AU - Wang, J. PY - 2017 DA - 2017// TI - Adverse events associated with treatment of multidrug-resistant tuberculosis in China: an ambispective cohort study JO - Med Sci Monit VL - 23 UR - https://doi.org/10.12659/MSM.904682 DO - 10.12659/MSM.904682 ID - Zhang2017 ER - TY - JOUR AU - Liu, Z. AU - Pan, A. AU - Wu, B. AU - Zhou, L. AU - He, H. AU - Meng, Q. PY - 2017 DA - 2017// TI - Feasibility of a new model for early detection of patients with multidrug-resistant tuberculosis in a developed setting of eastern China JO - Tropical Med Int Health VL - 22 UR - https://doi.org/10.1111/tmi.12934 DO - 10.1111/tmi.12934 ID - Liu2017 ER - TY - BOOK AU - Wang, Y. PY - 2012 DA - 2012// TI - Guidelines for the prevention and control of multidrug-resistant tuberculosis PB - Military Science Publishing House CY - Beijing ID - Wang2012 ER - TY - STD TI - WHO. WHO consolidated guidelines on drug-resistant tuberculosis treatment Geneva: World Health Organization; 2019 [Available from: https://www.who.int/tb/publications/2019/consolidated-guidelines-drug-resistant-TB-treatment/en/. UR - https://www.who.int/tb/publications/2019/consolidated-guidelines-drug-resistant-TB-treatment/en/ ID - ref14 ER - TY - STD TI - WHO. Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs Geneva: World Health Organization; 2008 [updated 2008. Available from: https://www.who.int/tb/publications/2008/whohtmtb_2008_392/en/. UR - https://www.who.int/tb/publications/2008/whohtmtb_2008_392/en/ ID - ref15 ER - TY - STD TI - WHO. Definitions and reporting framework for tuberculosis Geneva 2013 [updated December 2014. Available from: https://www.who.int/tb/publications/definitions/en/. UR - https://www.who.int/tb/publications/definitions/en/ ID - ref16 ER - TY - JOUR AU - Zignol, M. AU - Cabibbe, A. M. AU - Dean, A. S. AU - Glaziou, P. AU - Alikhanova, N. AU - Ama, C. PY - 2018 DA - 2018// TI - Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study JO - Lancet Infect Dis VL - 18 UR - https://doi.org/10.1016/S1473-3099(18)30073-2 DO - 10.1016/S1473-3099(18)30073-2 ID - Zignol2018 ER - TY - STD TI - TBC India. India TB report 2018 New Delhi: Central TB Division; 2018 [Available from: https://tbcindia.gov.in/showfile.php?lid=3314. UR - https://tbcindia.gov.in/showfile.php?lid=3314 ID - ref18 ER - TY - JOUR AU - Tang, S. AU - Wang, L. AU - Wang, H. AU - Chin, D. P. PY - 2016 DA - 2016// TI - Access to and affordability of healthcare for TB patients in China: issues and challenges JO - Infect Dis Poverty VL - 5 UR - https://doi.org/10.1186/s40249-016-0096-y DO - 10.1186/s40249-016-0096-y ID - Tang2016 ER - TY - JOUR AU - Yang, C. AU - Luo, T. AU - Shen, X. AU - Wu, J. AU - Gan, M. AU - Xu, P. PY - 2017 DA - 2017// TI - Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation JO - Lancet Infect Dis VL - 17 UR - https://doi.org/10.1016/S1473-3099(16)30418-2 DO - 10.1016/S1473-3099(16)30418-2 ID - Yang2017 ER - TY - JOUR AU - Zhao, Y. L. AU - Xu, S. F. AU - Wang, L. X. AU - Chin, D. P. AU - Wang, S. F. AU - Jiang, G. L. PY - 2012 DA - 2012// TI - National survey of drug-resistant tuberculosis in China JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1108789 DO - 10.1056/NEJMoa1108789 ID - Zhao2012 ER - TY - JOUR AU - Yin, J. AU - Wang, X. AU - Zhou, L. AU - Wei, X. PY - 2018 DA - 2018// TI - The relationship between social support, treatment interruption and treatment outcome in patients with multidrug-resistant tuberculosis in China: a mixed-methods study JO - Tropical Med Int Health VL - 23 UR - https://doi.org/10.1111/tmi.13066 DO - 10.1111/tmi.13066 ID - Yin2018 ER - TY - JOUR AU - Lunte, K. AU - Cordier-Lassalle, T. AU - Keravec, J. PY - 2015 DA - 2015// TI - Reducing the price of treatment for multidrug-resistant tuberculosis through the global drug facility JO - Bull World Health Organ VL - 93 UR - https://doi.org/10.2471/BLT.14.145920 DO - 10.2471/BLT.14.145920 ID - Lunte2015 ER - TY - JOUR AU - Floyd, K. AU - Hutubessy, R. AU - Kliiman, K. AU - Centis, R. AU - Khurieva, N. AU - Jakobowiak, W. PY - 2012 DA - 2012// TI - Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia JO - Eur Respir J VL - 40 UR - https://doi.org/10.1183/09031936.00169411 DO - 10.1183/09031936.00169411 ID - Floyd2012 ER - TY - JOUR AU - Svensson, E. M. AU - Svensson, R. J. AU - Brake, L. H. M. AU - Boeree, M. J. AU - Heinrich, N. AU - Konsten, S. PY - 2018 DA - 2018// TI - The potential for treatment shortening with higher rifampicin doses: relating drug exposure to treatment response in patients with pulmonary tuberculosis JO - Clin Infect Dis VL - 67 UR - https://doi.org/10.1093/cid/ciy026 DO - 10.1093/cid/ciy026 ID - Svensson2018 ER - TY - JOUR AU - He, G. X. AU - Xie, Y. G. AU - Wang, L. X. AU - Borgdorff, M. W. AU - Werf, M. J. AU - Fan, J. H. PY - 2010 DA - 2010// TI - Follow-up of patients with multidrug resistant tuberculosis four years after standardized first-line drug treatment JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0010799 DO - 10.1371/journal.pone.0010799 ID - He2010 ER - TY - JOUR AU - Chiang, C. Y. AU - Enarson, D. A. AU - Yu, M. C. AU - Bai, K. J. AU - Huang, R. M. AU - Hsu, C. J. PY - 2006 DA - 2006// TI - Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study JO - Eur Respir J VL - 28 UR - https://doi.org/10.1183/09031936.06.00125705 DO - 10.1183/09031936.06.00125705 ID - Chiang2006 ER - TY - JOUR AU - Pasipanodya, J. G. AU - McIlleron, H. AU - Burger, A. AU - Wash, P. A. AU - Smith, P. AU - Gumbo, T. PY - 2013 DA - 2013// TI - Serum drug concentrations predictive of pulmonary tuberculosis outcomes JO - J Infect Dis VL - 208 UR - https://doi.org/10.1093/infdis/jit352 DO - 10.1093/infdis/jit352 ID - Pasipanodya2013 ER - TY - JOUR AU - Cegielski, J. P. AU - Kurbatova, E. AU - Walt, M. AU - Brand, J. AU - Ershova, J. AU - Tupasi, T. PY - 2016 DA - 2016// TI - Multidrug-resistant tuberculosis treatment outcomes in relation to treatment and initial versus acquired second-line drug resistance JO - Clin Infect Dis VL - 62 ID - Cegielski2016 ER -